Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis

Diabetes

Volumn 62, Issue 1, 2013, Pages 158-169

  Basseri, Sana ^a,b   Lhoták, Šárka ^b   Fullerton, Morgan D ^a   Palanivel, Rengasamy ^a   Jiang, Hua ^c   Lynn, Edward G ^a,b   Ford, Rebecca J ^a   Maclean, Kenneth N ^c   Steinberg, Gregory R ^a   Austin, Richard C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLECKSTRIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; T CELL DEATH ASSOCIATED GENE 51 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY LIVER; FEEDING; FEMALE; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPOGENESIS; MALE; METABOLIC RATE; MOUSE; NONHUMAN; OBESITY; ONSET AGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; WILD TYPE;

3T3-L1 CELLS; ANIMALS; ENERGY METABOLISM; FATTY LIVER; INSULIN RESISTANCE; LIPOGENESIS; MALE; MICE; MICE, INBRED C57BL; OBESITY; THERMOGENESIS; TRANSCRIPTION FACTORS;

EID: 84872019531     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0256     Document Type: Article

References (50)

1. Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes 2004;53:2242-2249 (Pubitemid 39145577)
2. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev 2001;2:239-254 (Pubitemid 33755900)
3. Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999;4:611-617 (Pubitemid 29531140)
4. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994;79:1147-1156
5. Freytag SO, Geddes TJ. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 1992;256:379-382
6. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/ enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994;8:1654-1663 (Pubitemid 24236244)
7. Rosen ED, Hsu CH, Wang X, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unifi ed pathway. Genes Dev 2002;16:22 -26
8. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809 (Pubitemid 28340604)
9. Jernås M, Palming J, Sjöholm K, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006;20:1540-1542
10. Maffeis C, Silvagni D, Bonadonna R, Grezzani A, Banzato C, Tatò L. Fat cell size, insulin sensitivity, and inflammation in obese children. J Pediatr 2007;151:647-652 (Pubitemid 350116118)
11. Burton GR, Nagarajan R, Peterson CA, McGehee RE Jr. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene 2004;329:167-185 (Pubitemid 38366505)
12. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9:168-181
13. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995;64:345-373
14. Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr 2000;130:3122S-3126S (Pubitemid 32005353)
15. Frank D, Mendelsohn CL, Ciccone E, Svensson K, Ohlsson R, Tycko B. A novel pleckstrin homology-related gene family defined by Ipl/Tssc3, TDAG51, and Tih1: tissue-specific expression, chromosomal location, and parental imprinting. Mamm Genome 1999;10:1150-1159
16. Park CG, Lee SY, Kandala G, Lee SY, Choi Y. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 1996;4:583-591 (Pubitemid 26233312)
17. Rho J, Gong S, Kim N, Choi Y. TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. Mol Cell Biol 2001;21:8365-8370 (Pubitemid 33108597)
18. Gomes I, Xiong W, Miki T, Rosner MR. A proline- and glutamine-rich protein promotes apoptosis in neuronal cells. J Neurochem 1999;73:612-622 (Pubitemid 29339834)
19. Hayashida N, Inouye S, Fujimoto M, et al. A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. EMBO J 2006;25:4773-4783 (Pubitemid 44607023)
20. Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA. Downregulation of PHLDA1 gene expression is associated with breast cancer progression. Breast Cancer Res Treat 2007;106:49-56 (Pubitemid 47498092)
21. Neef R, Kuske MA, Pröls E, Johnson JP. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res 2002;62:5920-5929 (Pubitemid 35204755)
22. Hossain GS, van Thienen JV, Werstuck GH, et al. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem 2003;278:30317-30327 (Pubitemid 36962426)
23. Basseri S, Lhoták S, Sharma AM, Austin RC. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res 2009;50:2486-2501
24. Galic S, Fullerton MD, Schertzer JD, et al. Hematopoietic AMPK b1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 2011;121:4903-4915
25. Sachithanandan N, Fam BC, Fynch S, et al. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology 2010;52:1632-1642
26. O'Neill HM, Maarbjerg SJ, Crane JD, et al. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 2011;108:16092-16097
27. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509
28. Wei E, Alam M, Sun F, Agellon LB, Vance DE, Lehner R. Apolipoprotein B and triacylglycerol secretion in human triacylglycerol hydrolase transgenic mice. J Lipid Res 2007;48:2597-2606 (Pubitemid 350272844)
29. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917
30. Fullerton MD, Bakovic M. Complementation of the metabolic defect in CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)-deficient primary hepatocytes. Metabolism 2010;59:1691-1700
31. Dzamko N, van Denderen BJ, Hevener AL, et al. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem 2010;285:115-122
32. Ferré P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010;12(Suppl. 2):83-92
33. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 1999;96:12737-12742 (Pubitemid 29513572)
34. Shimano H, Yahagi N, Amemiya-Kudo M, et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999;274:35832-35839 (Pubitemid 129512888)
35. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761 (Pubitemid 40385531)
36. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 2002;967:363-378 (Pubitemid 34721922)
37. Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7:95-96 (Pubitemid 351168559)
38. Bae EJ, Xu J, Oh da Y, et al. Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance. J Biol Chem 2012;287:18769-18780
39. Sakurai M, Takamura T, Ota T, et al. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol 2007;42:312-317 (Pubitemid 46681707)
40. Ferreira DM, Castro RE, Machado MV, et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia 2011;54:1788-1798
41. Francque S, Verrijken A, Mertens I, et al. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes (Lond) 2011;35:270-278
42. Huang J, Jia Y, Fu T, et al. Sustained activation of PPARa by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 2012;26:628-638
43. Zhou QL, Jiang ZY, Mabardy AS, et al. A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes. J Biol Chem 2010;285:27581-27589
44. Toyoshima Y, Karas M, Yakar S, Dupont J, Lee Helman, LeRoith D. TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J Biol Chem 2004;279:25898-25904 (Pubitemid 38756856)
45. Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y, Kelly K. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer 2008;8:189
46. Lemmon MA, Ferguson KM. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 2000;350:1-18
47. Chakraborty A, Koldobskiy MA, Bello NT, et al. Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 2010;143:897-910
48. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003;31:3635-3641 (Pubitemid 37442212)
49. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009;4:363-371
50. Chan CB, Liu X, Jung DY, et al. Defi ciency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance. Diabetes 2010;59:883-893